3Enright RL,Connett JE,Bailey WC.The FEV1/FEV6 predicts lung function decline in adult smokes[J].Respir Med,2002,96(3):444-449.
4Swanney MP,Jensen RL,Crichton DA,et al.FEV6 is and acceptable surrogate for FVC in the spirometric diagnosis of airway obstraction and restriction[J].Am J Respir Crit Care Med,2000,162(3Pt1):917-919.
二级参考文献13
1Ferguson GT,Enright PL, Buist AS, et al. Ottice spirometry for lung health assessment in aduhs:A consensus statement from the National Lung Health Education Program. Chest,2000,117 : 1146-1161.
2Chitkara RK, Sarinas PS. Recent advances in diagnosis and management of chronic bronchitis and emphysema. Curt Opin Pulm Med ,2002,8 : 126-136.
3Enright RL,Connett JE, Bailey WC. The FEVI/FEV6 predicts lung function decline in adult smokers. Respir Med ,2002,96:444-449.
4Swanney MP,Jensen RL,Crichton DA,et al. FEV6 is an acceptable surrogate for FVC in the spimmetric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med,2000,162(3 Pt 1 ) :917-919.
5Johnson BD,Weisman IM, Zeballos RJ,et al. Emerging concepts in the evaluation of ventilatory limitation during exercise : the exercisetidal flow-volume loop. Chest, 1999,116:488-503.
6Milic-Emili J. Expiratory flow limitation:Roger S. Mitchell Lecture.Chest,2000,117 ( 5 Suppl 1 ) :219S-223S.
7Ehayara L, Becklake MR, Volta CA, et al. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1996,154(6 Pt 1) :1726-1734.
8Clotet J, Gomez-Arbones X, Ciria C, et al. Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care. Arch Bronconeumo1,2004,40 : 155 -159.
9Clevedey JR, Muller NL. Advances in radiologic assessment of chronic obstructive pulmonary disease. Clin Chest Med, 2000,21 :653-663.
10Shimizu K, Okazaki M, Akagi T,et al. Recent advances in computed tomography as a diagnostic tool for COPD. Nippon Rinsho,2003,61 :2144-2149.